Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

SALE OF COMMON STOCK (Details Narrative)

SALE OF COMMON STOCK (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands									1 Months Ended	2 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Apr. 08, 2020	Feb. 07, 2020	Nov. 14, 2019	Aug. 20, 2019	Dec. 13, 2018	Dec. 11, 2018	Dec. 07, 2018	Oct. 18, 2018	Feb. 28, 2020	Mar. 31, 2020	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Net proceeds													$ 300
Proceeds from the exercise of warrants													$ 7,474	$ 70
Number of options granted													10,100,250
Number of shares issued, value											$ 1,895
Net proceeds													$ 51,099	$ 420
Preferred stock deemed dividend											$ 1,260		$ 1,260
Issuance of common stock under 2019 Purchase Agreement (in share)													464,471
Warrants from Feb 7 Financing [Member]
Number of exercised warrants										10,800,000			10,800,000
Exercised price (in dollars per share)													$ 0.57
Proceeds from the exercise of warrants										$ 6,200			$ 6,200
Warrants from Nov 2019 Financing [Member]
Number of exercised warrants													2,300,000
Exercised price (in dollars per share)										$ 0.57	$ 0.57		$ 0.57
Proceeds from the exercise of warrants													$ 1,300
Series B Convertible Preferred Stock [Member]
Number of shares converted (in shares)											5,313
Series A Convertible Preferred Stock [Member]
Number of shares converted (in shares)												9,856
Issuance of Series A Convertible preferred stock and common stock warrants (in shares)															7,938
Shares issue upon conversion of preferred stock (shares)												281,610
2018 Purchase Agreement [Member]
Number of units sold													22,754
Percentage of underwriting discount													19.90%
Net proceeds													$ 400
2018 Purchase Agreement [Member] \| Lincoln Park Capital Fund, LLC [Member]
Number of shares issued (in shares)								3,500
Commitment to purchase shares under agreement								$ 15,000
Number of shares issued, value								$ 245
Underwriting Agreement [Member] \| Alliance Global Partners [Member]
Sale of stock, price (in dollars per share)									$ 1.10
Percentage of underwriting discount			7.00%						7.00%
Underwriting discount									$ 1,100
Net proceeds
Offering expenses			$ 500						$ 100
Number of shares issued (in shares)									14,550,000
Net proceeds			$ 7,900
Underwriting Agreement [Member] \| Alliance Global Partners [Member] \| Class A Units [Member]
Sale of stock, price (in dollars per share)			$ 1.94
Issuance of common stock and common stock warrants (in shares)			547,420
Number of common shares per unit			1
Issue of shares at discount			$ 600
Underwriting Agreement [Member] \| Alliance Global Partners [Member] \| Class B Units [Member]
Sale of stock, price (in dollars per share)			$ 1,000
Issuance of Series A Convertible preferred stock and common stock warrants (in shares)			7,938
Underwriting Agreement [Member] \| Alliance Global Partners [Member] \| Warrants [Member]
Exercised price (in dollars per share)			$ 1.94
Warrants expiration period			5 years
Underwriting Agreement [Member] \| Alliance Global Partners [Member] \| Warrants [Member] \| Class B Units [Member]
Number of warrants to purchase to common stock per unit			515.464
Underwriting Agreement [Member] \| Alliance Global Partners [Member] \| Common Warrants [Member]
Exercised price (in dollars per share)			$ 1.94
Value of securities traded to trigger exercise of warrants			$ 9,000
Warrants expiration period			12 months
Underwriting Agreement [Member] \| Alliance Global Partners [Member] \| Common Warrants [Member] \| Class B Units [Member]
Number of warrants to purchase to common stock per unit			257.732
Underwriting Agreement [Member] \| Alliance Global Partners Dawson James Securities Inc [Member] \| Class A Units [Member]
Sale of stock, price (in dollars per share)							$ 35.00
Issuance of common stock and common stock warrants (in shares)							86,171
Number of common shares per unit							1
Number of warrants to purchase to common stock per unit							1
Number of options granted							64,286
Number of options granted, term							45 days
Number of warrants granted							64,286
Underwriting Agreement [Member] \| Alliance Global Partners Dawson James Securities Inc [Member] \| Class B Units [Member]
Sale of stock, price (in dollars per share)							$ 1,000
Number of shares of common stock convertible							28.5714
Exercised price (in dollars per share)							$ 35.00
Issuance of Series A Convertible preferred stock and common stock warrants (in shares)							11,984
Number of warrants to purchase to common stock per unit							28.5714
Number of convertible preferred stock per unit							1
Warrants expiration period							5 years
Conversion price per share							$ 35.00
Underwriting Agreement [Member] \| Alliance Global Partners Dawson James Securities Inc [Member] \| Over-Allotment Option [Member]
Underwriting discount					$ 100
Number of shares issued (in shares)					25,000
Net proceeds					$ 800
Underwriting discount per share (in dollars per share)					$ 2.40
Underwriting Agreement [Member] \| Alliance Global Partners Dawson James Securities Inc [Member] \| Over-Allotment Option [Member] \| Class A Units [Member]
Number of shares issued (in shares)						64,000
Net proceeds						$ 6
Underwriting Agreement [Member] \| Alliance Global Partners Dawson James Securities Inc [Member] \| Public Offering [Member] \| Class A Units [Member]
Percentage of underwriting discount						7.00%
Underwriting discount						$ 1,100
Offering expenses						400
Net proceeds						$ 13,600
Underwriting discount per share (in dollars per share)						$ 2.40
Preferred stock deemed dividend						$ 3,300
Underwriting Agreement [Member] \| Class A Unit [Member]
Number of units sold		3,837,000
Sale of stock, price (in dollars per share)		$ 0.57
Underwriting Agreement [Member] \| Class B Unit [Member]
Number of units sold		5,313
Sale of stock, price (in dollars per share)		$ 1,000
Conversion price (in dollars per share)		$ 0.57
Number of shares of common stock convertible		1,754.386
Number of warrants issued		1,754.386
Exercised price (in dollars per share)		$ 0.57
Warrant term		5 years
Underwriting Agreement [Member] \| Class B Unit [Member] \| Alliance Global Partners [Member] \| IPO [Member]
Percentage of underwriting discount		7.00%
Underwriting discount		$ 500
Net proceeds		6,500
Offering expenses		500
Preferred stock deemed dividend		$ 1,300
Underwriting Agreement [Member] \| Series A Convertible Preferred Stock [Member] [Default Label] \| Alliance Global Partners [Member] \| Class B Units [Member]
Preferred stock deemed dividend			$ 2,500
2019 Purchase Agreement [Member] \| Lincoln Park Capital Fund, LLC [Member]
Number of shares issued (in shares)				35,529
Commitment to purchase shares under agreement				$ 15,000
Number of shares issued, value				$ 200
Sales Agreement [Member] \| Alliance Global Partners [Member]
Number of units sold	5,300,000
Net proceeds	$ 35,300
Offering price at-the-market offerings	$ 50,000
Commission to agent	3.00%